IT1299566B1 - Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina - Google Patents

Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina

Info

Publication number
IT1299566B1
IT1299566B1 IT98RM000479A ITRM980479A IT1299566B1 IT 1299566 B1 IT1299566 B1 IT 1299566B1 IT 98RM000479 A IT98RM000479 A IT 98RM000479A IT RM980479 A ITRM980479 A IT RM980479A IT 1299566 B1 IT1299566 B1 IT 1299566B1
Authority
IT
Italy
Prior art keywords
norapropylapomorphine
hydrochloride
pharmaceutical compositions
transdermal patch
compositions including
Prior art date
Application number
IT98RM000479A
Other languages
English (en)
Inventor
Gian Luigi Gessa
Original Assignee
Ifi Istituto Farmacoterapico I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ifi Istituto Farmacoterapico I filed Critical Ifi Istituto Farmacoterapico I
Publication of ITRM980479A0 publication Critical patent/ITRM980479A0/it
Priority to IT98RM000479A priority Critical patent/IT1299566B1/it
Priority to PCT/IE1999/000066 priority patent/WO2000003698A1/en
Priority to US09/743,576 priority patent/US6592893B1/en
Priority to CA002337516A priority patent/CA2337516A1/en
Priority to JP2000559833A priority patent/JP2002520352A/ja
Priority to CNB998086673A priority patent/CN1195503C/zh
Priority to AU46434/99A priority patent/AU764025B2/en
Priority to EP99929658A priority patent/EP1098637A1/en
Publication of ITRM980479A1 publication Critical patent/ITRM980479A1/it
Application granted granted Critical
Publication of IT1299566B1 publication Critical patent/IT1299566B1/it
Priority to NO20010248A priority patent/NO20010248D0/no
Priority to ZA200100406A priority patent/ZA200100406B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
IT98RM000479A 1998-07-17 1998-07-17 Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina IT1299566B1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT98RM000479A IT1299566B1 (it) 1998-07-17 1998-07-17 Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina
JP2000559833A JP2002520352A (ja) 1998-07-17 1999-07-15 プロピルノルアポモルフィンを含有する経皮性パッチならびに局所性組成物
US09/743,576 US6592893B1 (en) 1998-07-17 1999-07-15 Transdermal patch and topical compositions comprising propylnorapomorphine
CA002337516A CA2337516A1 (en) 1998-07-17 1999-07-15 Transdermal patch and topical compositions comprising propylnorapomorphine
PCT/IE1999/000066 WO2000003698A1 (en) 1998-07-17 1999-07-15 Transdermal patch and topical compositions comprising propylnorapomorphine
CNB998086673A CN1195503C (zh) 1998-07-17 1999-07-15 含有丙基去甲阿朴吗啡的透皮药贴和局部用组合物
AU46434/99A AU764025B2 (en) 1998-07-17 1999-07-15 Transdermal patch and topical compositions comprising propylnorapomorphine
EP99929658A EP1098637A1 (en) 1998-07-17 1999-07-15 Transdermal patch and topical compositions comprising propylnorapomorphine
NO20010248A NO20010248D0 (no) 1998-07-17 2001-01-15 Transdermalt plaster og topiske sammensetninger omfattende propylnorapomorfin
ZA200100406A ZA200100406B (en) 1998-07-17 2001-01-15 Transdermal patch and topical compositions comprising propylnorapomorphine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98RM000479A IT1299566B1 (it) 1998-07-17 1998-07-17 Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina

Publications (3)

Publication Number Publication Date
ITRM980479A0 ITRM980479A0 (it) 1998-07-17
ITRM980479A1 ITRM980479A1 (it) 2000-01-17
IT1299566B1 true IT1299566B1 (it) 2000-03-16

Family

ID=11406053

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98RM000479A IT1299566B1 (it) 1998-07-17 1998-07-17 Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina

Country Status (10)

Country Link
US (1) US6592893B1 (it)
EP (1) EP1098637A1 (it)
JP (1) JP2002520352A (it)
CN (1) CN1195503C (it)
AU (1) AU764025B2 (it)
CA (1) CA2337516A1 (it)
IT (1) IT1299566B1 (it)
NO (1) NO20010248D0 (it)
WO (1) WO2000003698A1 (it)
ZA (1) ZA200100406B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0109515A (pt) * 2000-04-07 2004-08-10 Tap Pharmaceutical Prod Inc Derivados da apomorfina e métodos para seu uso
SE0002934D0 (sv) 2000-08-17 2000-08-17 Axon Biochemicals Bv New aporphine esters and in their use in therapy
DE10110953A1 (de) * 2001-03-07 2002-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von partiellen Dopamin-D2-Agonisten
MXPA06004460A (es) * 2003-10-23 2006-06-27 Cipla Ltd Formulaciones en aerosol farmaceuticas transdermicas que comprenden un copolimero de vp/av y un vehiculo no acuoso.
JP4919807B2 (ja) 2004-11-10 2012-04-18 久光製薬株式会社 外用製剤及び貼付剤
RU2435570C2 (ru) * 2006-12-01 2011-12-10 Нитто Денко Корпорейшн Композиция для чрескожного всасывания
US20080131490A1 (en) * 2006-12-01 2008-06-05 Akinori Hanatani Stabilized donepezil-containing patch preparation
CN102046171B (zh) * 2008-05-30 2013-06-19 日东电工株式会社 经皮吸收制剂
CN102014905B (zh) * 2008-05-30 2012-11-14 日东电工株式会社 含有多奈哌齐的贴剂及其包装体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126616A (en) * 1975-11-10 1978-11-21 William B. Hinshaw N-propylnorapomorphine diesters
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
FR2732896B1 (fr) * 1995-04-11 1997-06-13 Prographarm Lab Forme pharmaceutique transdermique pour l'administration percutanee de l'apomorphine
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation

Also Published As

Publication number Publication date
ZA200100406B (en) 2001-10-31
CN1195503C (zh) 2005-04-06
JP2002520352A (ja) 2002-07-09
NO20010248L (no) 2001-01-15
WO2000003698A1 (en) 2000-01-27
ITRM980479A1 (it) 2000-01-17
AU764025B2 (en) 2003-08-07
CN1309558A (zh) 2001-08-22
US6592893B1 (en) 2003-07-15
NO20010248D0 (no) 2001-01-15
AU4643499A (en) 2000-02-07
CA2337516A1 (en) 2000-01-27
ITRM980479A0 (it) 1998-07-17
EP1098637A1 (en) 2001-05-16

Similar Documents

Publication Publication Date Title
FI991485A0 (fi) Uusi farmaseuttinen koostumus
NO20012915L (no) Ny farmasöytisk formulering
PT1011621E (pt) Metodos e composicoes para branqueamento dos dentes
ID27415A (id) Komposisi farmaseutik
ITMI981889A0 (it) Cerotto transdermico
ATE220545T1 (de) Fentanyl enthaltendes transdermal-pflaster
ITMI982280A0 (it) Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
NO20015175L (no) Farmasöytisk sammensetning
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
NO20005913D0 (no) Legemiddelsammensetning
PT1066027E (pt) Composicao farmaceutica de topiramato
BR9813284B1 (pt) aminoácidos cìclicos e derivados dos mesmos úteis como agentes farmacêuticos e composição farmacêutica.
EE200000488A (et) Fosfolipaasensüümide inhibiitorid ja farmatseutilised kompositsioonid
EE200100022A (et) Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
ID29262A (id) Komposisi farmasi
NO20006604D0 (no) Fremgangsmåter og transdermale sammensetninger for lindring av smerte
NO20006488D0 (no) Sammensetning og anvendelse
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
ID27201A (id) Komposisi farmasi
IS2841B (is) Samstæða hluta og lyfjasamsetningar
IT1299566B1 (it) Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina
PT1140110E (pt) Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
DE69907538D1 (de) Gewebeschutzmittel gegen Schädlinge
ID30032A (id) Formulasi farmasi

Legal Events

Date Code Title Description
0001 Granted